Giant cell tumour of the bone treated with denosumab: How has the blood supply and oncological prognosis of the tumour changed?

BACKGROUND: Denosumab is gradually applied to refractory or unresectable giant cell tumour of the bone. Whether denosumab can effectively reduce the blood supply of tumour and bring benefit is worthy of study. The aim of the study is to evaluate the related changes after treatment: blood supply, sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Xiaohui, Yang, Yongkun, Wong, Kwok Chuen, Huang, Zhen, Ding, Yi, Zhang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Speaking Orthopaedic Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718948/
https://www.ncbi.nlm.nih.gov/pubmed/31508313
http://dx.doi.org/10.1016/j.jot.2018.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718948/
https://www.ncbi.nlm.nih.gov/pubmed/31508313
http://dx.doi.org/10.1016/j.jot.2018.10.003

Ejemplares similares